Not Yet RecruitingNot applicableNCT07720141

Dissemination Of Lung Cancer Screening Education Through Tobacco Quitlines

The goal of this research study is to compare two different ways to increase lung cancer screening rates for tobacco quitline clients.

Checked against the public recordLast updated Jul 22, 2026 · Source: ClinicalTrials.gov

StatusNot Yet Recruiting
PhaseNot applicable
U.S. locations1
SponsorM.D. Anderson Cancer Center
01
Study overview

What this study is about

Purpose
Prevention
Study type
Interventional
Phase
Not applicable
Sponsor
M.D. Anderson Cancer Center
Interventions being studied
Behavioral: High-touch strategy
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

Inclusion Criteria: Quitline Client Quitline client participants must meet the criteria for LCS with regards to age (50 to 80 years) and smoking history (20+ pack-years). This project will not re-confirm quitline client participant eligibility for screening. Tobacco treatment specialists will elicit study interest from only eligible quitline clients. Representative of the Quitline Community Representative of the Quitline Community will include any employee of the quitline service provider, representative from an organization that collaborates or funds a tobacco quitline, and/or a representative of the state department of health. All individuals will be adults (18 years and older) and able to speak English. Representative of the Healthcare Sector Representative of the healthcare sector will include any adult who works in healthcare, including but not limited to physicians, healthcare administrative leaders/managers, nurses, advanced practice providers. All individuals will be adults (18 years and older) and able to speak English. Exclusion Criteria: Not applicable as our focus on quitline clients and representatives (adults) of the quitline community or the healthcare sector.

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • UT MD AndersonHouston, Texas

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jul 22, 2026. Always confirm current availability with the study team.

View original record ↗